NFκB Signalling in Colorectal Cancer: Examining the Central Dogma of IKKα and IKKβ Signalling

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jul 8

PMID 38975078

Authors

Molly McKenzie

Guang-Yu Lian

Kathryn A F Pennel

Jean A Quinn

Nigel B Jamieson

Joanne Edwards

Affiliations

Soon will be listed here.

Abstract

The NFκB pathway, known as the central regulator of inflammation, has a well-established role in colorectal cancer (CRC) initiation, progression, and therapy resistance. Due to the pathway's overarching roles in CRC, there have been efforts to characterise NFκB family members and target the pathway for therapeutic intervention. Initial research illustrated that the canonical NFκB pathway, driven by central kinase IKKβ, was a promising target for drug intervention. However, dose limiting toxicities and specificity concerns have resulted in failure of IKKβ inhibitors in clinical trials. The field has turned to look at targeting the less dominant kinase, IKKα, which along with NFκB inducing kinase (NIK), drives the lesser researched non-canonical NFκB pathway. However prognostic studies of the non-canonical pathway have produced conflicting results. There is emerging evidence that IKKα is involved in other signalling pathways, which lie outside of canonical and non-canonical NFκB signalling. Evidence suggests that some of these alternative pathways involve a truncated form of IKKα, and this may drive poor cancer-specific survival in CRC. This review aims to explore the multiple components of NFκB signalling, highlighting that NIK may be the central kinase for non-canonical NFκB signalling, and that IKKα is involved in novel pathways which promote CRC.

References

Abd El Fattah Y, Abulsoud A, Abdelhamid S, AbdelHalim S, Hamdy N . CCDC144NL-AS1/hsa-miR-143-3p/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision. Int J Biol Macromol. 2023; 253(Pt 2):126739. DOI: 10.1016/j.ijbiomac.2023.126739. View

Jia J, Shi Y, Yan B, Xiao D, Lai W, Pan Y . LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway. Oncotarget. 2016; 7(19):27280-94. PMC: 5053649. DOI: 10.18632/oncotarget.8465. View

Emam O, Wasfey E, Hamdy N . Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer. Cancer Cell Int. 2022; 22(1):316. PMC: 9558410. DOI: 10.1186/s12935-022-02736-2. View

Soleimani A, Rahmani F, Ferns G, Ryzhikov M, Avan A, Hassanian S . Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer. Gene. 2019; 726:144132. DOI: 10.1016/j.gene.2019.144132. View

Yang M, Sun L, Han J, Zheng C, Liang H, Zhu J . Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis. Mol Brain. 2019; 12(1):115. PMC: 6935142. DOI: 10.1186/s13041-019-0532-6. View

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

Turpin P, Rodriguez M, Thomas D, Hay R, Virelizier J, Dargemont C . Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci. 1997; 110 ( Pt 3):369-78. DOI: 10.1242/jcs.110.3.369. View

Li Y, Lin Z, Chen B, Chen S, Jiang Z, Zhou T . Ezrin/NF-kB activation regulates epithelial- mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer. Biomed Pharmacother. 2017; 92:140-148. DOI: 10.1016/j.biopha.2017.05.058. View

Margalef P, Colomer C, Villanueva A, Montagut C, Iglesias M, Bellosillo B . BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent. Sci Signal. 2015; 8(373):ra38. DOI: 10.1126/scisignal.2005886. View

10.

Polley S, Oliveira Passos D, Huang D, Mulero M, Mazumder A, Biswas T . Structural Basis for the Activation of IKK1/α. Cell Rep. 2016; 17(8):1907-1914. PMC: 5508515. DOI: 10.1016/j.celrep.2016.10.067. View

11.

Alexander P, McMillan D, Park J . The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis. Cancer Treat Rev. 2019; 83:101949. DOI: 10.1016/j.ctrv.2019.101949. View

12.

Zhong H, May M, Jimi E, Ghosh S . The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002; 9(3):625-36. DOI: 10.1016/s1097-2765(02)00477-x. View

13.

Margalef P, Fernandez-Majada V, Villanueva A, Garcia-Carbonell R, Iglesias M, Lopez L . A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer. Cell Rep. 2012; 2(4):840-54. DOI: 10.1016/j.celrep.2012.08.028. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Israel A . The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010; 2(3):a000158. PMC: 2829958. DOI: 10.1101/cshperspect.a000158. View

16.

Pham A, tenOever B . The IKK Kinases: Operators of Antiviral Signaling. Viruses. 2011; 2(1):55-72. PMC: 3185564. DOI: 10.3390/v2010055. View

17.

Yang X, Sun S . Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Immunol Rev. 2015; 266(1):56-71. PMC: 4473799. DOI: 10.1111/imr.12311. View

18.

Xia Y, Shen S, Verma I . NF-κB, an active player in human cancers. Cancer Immunol Res. 2014; 2(9):823-30. PMC: 4155602. DOI: 10.1158/2326-6066.CIR-14-0112. View

19.

Martin M, Sun M, Motolani A, Lu T . The Pivotal Player: Components of NF-κB Pathway as Promising Biomarkers in Colorectal Cancer. Int J Mol Sci. 2021; 22(14). PMC: 8303169. DOI: 10.3390/ijms22147429. View

20.

Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W . Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res. 2009; 15(7):2248-58. DOI: 10.1158/1078-0432.CCR-08-1383. View